Synthesis and Characterization of Novel Nanoparticles for Targeted Cancer Therapy

Authors

  • Dr. Gayathri Raghuram Author

Keywords:

Cancer, Nanomedicine, Targeted Nanoparticles.

Abstract

The use of nanoparticles in carrier-drug systems improves tumour inhibition and lowers drug-related side effects, according to recent studies on silver nanoparticles. The fusion of conventional medicine with nanotechnology presents an opportunity to create novel antimicrobial agents concurrently. This work aimed to identify the pro-apoptotic properties, anticancer, and antibacterial properties of silver nanoparticles (AgNPs) and AgNPs-Car, the latter of which were loaded with carboplatin. DLS, EDX-STEM, and FTIR analysis were used to conduct characterisation studies of the synthesised nanoparticles. The outcomes showed that AgNPs-Car effectively targeted C6 glioma cells by encouraging medication entrance into the cell. Additionally, the toxicity was minimal and the anticancer efficacy against MCF-7 and A549 cells was strong. Silver nanoparticles are the favoured material because of their superior quality and ability to improve medication delivery. Consequently, it is a promising field of study for the focused combat of cancer cells and harmful microbes. Silver nanoparticles are the favoured material because of their superior quality and ability to improve medication delivery. Consequently, it is a promising field of study for the focused combat of cancer cells and harmful microbes.

Downloads

Published

2024-12-20

Issue

Section

Articles

How to Cite

Raghuram, G. (2024). Synthesis and Characterization of Novel Nanoparticles for Targeted Cancer Therapy. Clinical Journal for Medicine, Health and Pharmacy, 2(4), 21-30. http://cjmhp.com/index.php/journal/article/view/22